Showing results (1041-1050 of 4,514) with videos related to
Sort By:
Pageof 452
Future Oncology (London, England)|August 18, 2023
The MOTION study: a randomized, phase III study of vimseltinib for the treatment of tenosynovial giant cell tumorWilliam D Tap, Maitreyi G Sharma, Marc Vallee, et al.Future Oncology (London, England)|January 8, 2024
CREST: phase III study of sasanlimab and Bacillus Calmette-Guérin for patients with Bacillus Calmette-Guérin-naïve high-risk non-muscle-invasive bladder cancerGary D Steinberg, Neal D Shore, Joan Palou Redorta, et al.Future Oncology (London, England)|January 8, 2024
Bacterial heat shock protein genes during induction chemotherapy in pediatric patients with acute lymphoblastic leukemiaKatherine A Dunn, Emma MacDonald, Tamara MacDonald, et al.Future Oncology (London, England)|January 17, 2024
Real-world comparative effectiveness of palbociclib plus aromatase inhibitor in HR+/HER2- metastatic breast cancerNicholas Robert, Connie Chen, Sindy Kim, et al.Future Oncology (London, England)|January 17, 2024
Treatment patterns and costs among US patients with diffuse large B-cell lymphoma not treated with 2L stem cell transplantationTeofilia Acheampong, Tao Gu, Trong Kim Le, et al.Future Oncology (London, England)|December 13, 2023
Detection of NTRK gene fusions in solid tumors: recommendations from a Latin American group of oncologists and pathologistsMauricio Cuello, Hernán García-Rivello, Fuad Huamán-Garaicoa, et al.Future Oncology (London, England)|November 29, 2023
A new fluorescenttargeting tracer contrasts dual tracers in sentinel lymph node biopsy of breast cancerShuang Wu, Panpan Li, Qingsong Zhang, et al.Future Oncology (London, England)|December 5, 2023
Prognostic role of sodium levels in colorectal cancer patients receiving aflibercept plus FOLFIRIMartina Catalano, Daniele Lavacchi, Elisa Giommoni, et al.Future Oncology (London, England)|November 28, 2023
Genetic testing and counseling challenges in personalized breast cancer care: review article with insights from TürkiyeIrfan Cicin, Nuri Karadurmus, Ahmet Bilici, et al.Future Oncology (London, England)|November 27, 2023
Long-term benefit of sotorasib in patients with KRAS G12C-mutated non-small-cell lung cancer: plain language summaryGrace K Dy, Ramaswamy Govindan, Vamsidhar Velcheti, et al.Pageof 452